Delivery Order SPE2DR25D1109-SPE2DR26FFH2V
Award Date 12/2/25
Potential Completion Date 12/3/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,415.04 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price contract was executed on December 10, 2025, with an ultimate completion date of December 11, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,991.50 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 25, 2025, with ultimate completion scheduled for August 26, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract specifies performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5ml syringes, valued at $1,922.28 with a firm fixed price structure. The order was competitively awarded without set-aside designation and is scheduled for completion by December 9, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency has awarded a delivery order valued at $3,804.30 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes, with a completion deadline of December 3, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $71,577.02 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $105,282 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on November 18, 2025, with an ultimate completion date of November 19, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,372.94 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract, classified as firm fixed price with no set-aside designation, was awarded on October 22, 2025, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine syringes (0.5mL) valued at $1,884.48. This firm fixed-price delivery order, awarded on October 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringe format. The contract is valued at $1,286.40 with a firm fixed price and carries an ultimate completion date of December 8, 2025. This is a non-set-aside award issued under a competitive procurement process, with performance to take place at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $213,546 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is also located in Conshohocken, where AmerisourceBergen maintains its corporate office and primary...